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Abstract 1 
Glutamate and K+, both released during neuronal firing, need to be tightly regulated to ensure 2 
accurate synaptic transmission. Extracellular glutamate and K+ ([K+]o) are rapidly taken up by 3 
glutamate transporters and K+-transporters or channels, respectively. Glutamate transport 4 
includes the exchange of one glutamate, three Na+, and one proton, in exchange for one K+. This 5 
K+ efflux allows the glutamate binding site to reorient in the outwardly facing position and start a 6 
new transport cycle. Here, we demonstrate the sensitivity of the transport process to [K+]o 7 
changes. Increasing [K+]o over the physiological range had an immediate and reversible inhibitory 8 
action on glutamate transporters. This K+-dependent transporter inhibition was revealed using 9 
microspectrofluorimetry in primary astrocytes, and whole-cell patch-clamp in acute brain slices 10 
and HEK293 cells expressing glutamate transporters. Previous studies demonstrated that 11 
pharmacological inhibition of glutamate transporters decreases neuronal transmission via 12 
extrasynaptic glutamate spillover and subsequent activation of metabotropic glutamate receptors 13 
(mGluRs). Here, we demonstrate that increasing [K+]o also causes a decrease in neuronal 14 
mEPSC frequency, which is prevented by group II mGluR inhibition. These findings highlight a 15 
novel, previously unreported physiological negative feedback mechanism in which [K+]o 16 
elevations inhibit glutamate transporters, unveiling a new mechanism for activity-dependent 17 
modulation of synaptic activity. 18 
 19 
 20 
Keywords: astrocyte, electrophysiology, metabotropic glutamate receptors, sodium imaging. 21 
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Introduction  1 
Glutamate, which is released in the synaptic cleft during neuronal activity, is the predominant 2 
excitatory neurotransmitter in the mammalian CNS. Extracellular glutamate is taken up against 3 
its concentration gradient by excitatory amino-acid transporters such as GLAST and GLT-1. 4 
These transporters are mainly expressed at the astrocytic (Rothstein et al. 1994) and, to a lesser 5 
degree, at the neuronal membranes (Rimmele and Rosenberg 2016). Fast removal of glutamate 6 
from the synaptic cleft is pivotal for signal transmission accuracy and prevention of over-7 
excitation. To date, the modulation of glutamate uptake on excitatory neurotransmission has been 8 
studied in regards to changes in astrocytic coverage (Oliet et al. 2001), and action of 9 
pharmacological inhibitors (Maki et al. 1994; Iserhot et al. 2004; Tsukada et al. 2005). Here, 10 
however, we evidenced and characterized physiological modulation of glutamate transport itself. 11 
Glutamate transport is driven by the inwardly directed Na+ gradient across the plasma membrane 12 
(Levy et al. 1998; Danbolt 2001). Transporting one glutamate into the cell is electrogenic as it is 13 
accompanied by the uptake of three Na+ and one H+, and by the extrusion of one K+ (Brew and 14 
Attwell 1987; Szatkowski et al. 1990; Barbour et al. 1994; Zerangue and Kavanaugh 1996; 15 
Bergles and Jahr 1997; Levy et al. 1998). This release of K+ is proposed to be compulsory for the 16 
glutamate transporter to start a new uptake cycle (Kanner 2006). Transporters of other 17 
neurotransmitters such as GABA or homologs of glutamate transporters from prokaryotes do not 18 
share this K+ component (Slotboom et al. 1999; Kanner 2006).  19 
During neuronal activity, K+ is released from repolarizing neurons, as well as extruded from AMPA 20 
and NMDA receptors (AMPAR, NMDAR) at the synaptic cleft (Shih et al. 2013). While the resting 21 
extracellular K+ concentration ([K+]o) is around 3mM, during intense activity [K+]o increases and 22 
can reach ~12mM (Kofuji and Newman 2004). Even higher concentrations are reached in 23 
pathological situations such as spreading depression. Glutamate and K+ regulation, which are 24 
pivotal astrocytic functions, have so far only been studied separately or under non-physiological 25 
conditions, e.g. 30-60mM [K+]o (Rossi et al. 2000). One glutamate taken up by glutamate 26 
transporter is linked to the efflux of one K+ into the extracellular space at the time K+ needs to be 27 
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cleared out of the extracellular space. Thus, the two functions work against each other regarding 1 
K+ movements.  2 
The aim of this study was to investigate the cross-talk between glutamate transport and [K+]o, and 3 
its functional consequences. In particular, we investigated the impact of altered [K+]o on glutamate 4 
transporter activity, monitored in primary astrocytes, HEK293 cells expressing GLT-1, and in 5 
astrocytes of mouse acute cortical slices. We then evaluated the functional outcome of these 6 
interactions on neuronal function in acute cortical slices. We demonstrate for the first time that 7 
[K+]o exerts tight control over the kinetics of the glutamate transporter. A moderate increase in 8 
[K+]o, as observed in physiological conditions, scales down glutamate uptake. This reduced 9 
glutamate clearance decreases neurotransmission notably through activation of mGluRs, 10 
inhibiting presynaptic glutamate release. These findings reveal a novel negative feedback 11 
cascade linking [K+]o elevation, glutamate transporter inhibition, and presynaptic mGluR activation, 12 
which together provide the basis for a previously unseen activity-dependent neuromodulatory 13 
mechanism. 14 
  15 
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Material and Methods  1 
Animals 2 
All experimental procedures were approved by the Veterinary Affairs Office of the Canton of Vaud, 3 
Switzerland (authorization number 1288.5-6) and were conducted in strict accordance with the 4 
animal care guidelines outlined in the Swiss Ordinance on Animal Experimentation in order to 5 
minimize the number and suffering of animals used in all experiments of this study. 6 
Cell culture  7 
Cortical astrocytes in primary culture were prepared from 1- to 3-days-old C57BL/6 mice as 8 
described elsewhere (Sorg and Magistretti 1992). Astrocytes were plated on coverslips and 9 
cultured for 3–4 weeks in DME medium (DMEM) plus 10% FCS before experiments. HEK293 10 
cells stably expressing GLT-1 (HEK-GLT-1) were also cultured in DMEM, and plated on coverslips 11 
the day before experiments. 12 
Fluorescence imaging and astrocyte transfection 13 
Low-light level fluorescence imaging was performed on an inverted epifluorescence microscope 14 
(Axiovert 100M, Carl Zeiss) using a 40 x 1.3 N.A. oil-immersion objective lens. Fluorescence 15 
excitation wavelengths were selected using a monochromator (Till Photonics) and fluorescence 16 
was detected using a 12-bit cooled CCD camera (Princeton Instruments) or EM-CCD camera 17 
(Andor). Image acquisition was computer-controlled using Metafluor software (Molecular 18 
Devices). Dye-loaded cells were placed in a thermostated chamber designed for rapid exchange 19 
of perfusion solutions (Chatton et al. 2000) and superfused at 35°C.  20 
Experimental solutions contained (mM) NaCl, 135; KCl, 5.4; NaHCO3, 25; CaCl2, 1.3; MgSO4, 21 
0.8; and NaH2PO4, 0.78, glucose, 5, bubbled with 5% CO2/95% air. Bicarbonate-free HEPES-22 
solutions contained (mM) NaCl, 160; KCl, 5.4; HEPES, 20; CaCl2, 1.3; MgSO4, 0.8; NaH2PO4, 23 
0.78; glucose, 5; bubbled with air. When using different K+ concentrations (3-15mM), NaCl was 24 
adjusted to maintain isotonicity. Solutions for dye loading contained (mM) NaCl, 160; KCl, 5.4; 25 
HEPES, 20; CaCl2, 1.3; MgSO4, 0.8; NaH2PO4, 0.78; glucose, 20 and were supplemented with 26 
Cerebral Cortex, June 2017;27: 3272–3283  Rimmele, Rocher, Wellbourne-Wood & Chatton 
 
6 
 
0.1% Pluronic F-127 (Molecular Probes). In experiments involving more than one solution 1 
application, the order was alternated between experiments in order to exclude order-related 2 
effects. 3 
For Na+ imaging experiments, astrocytes were loaded at 37°C for 40min with the Na+-sensitive 4 
indicator Asante Natrium Green-1 acetoxymethyl ester (ANG-1,  10µM, TEFLabs) (Lamy and 5 
Chatton 2011). ANG-1 fluorescence was excited at 515nm and detected at 535-585nm. For in 6 
situ calibration, cells were permeabilized for monovalent cations using 10μg/ml monensin, 3μg/ml 7 
gramicidin with simultaneous inhibition of the Na+/K+-ATPase by 1mM ouabain as described 8 
earlier (Chatton et al. 2000). This ouabain concentration causes maximal inhibition of Na+/K+- 9 
ATPase. Cells were then sequentially perfused with solutions buffered at pH 7.2 with 20mM 10 
HEPES and containing 0, 5, 10, 20, 50, 100mM Na+, respectively, and 30mM Cl−, 135mM 11 
gluconate with a constant total concentration of Na+ and K+ of 160mM. Experiments using Sodium 12 
binding benzofuran isophthalate-acetoxymethyl ester (SBFI, Teflabs) were performed as 13 
described before (Chatton et al. 2000). 14 
Intracellular Mg2+ was monitored using the fluorescent probe Magnesium Green-AM (MgG, 15 
Invitrogen), loaded at 37°C for 20min with 14µM dye. MgG fluorescence was imaged as previously 16 
described (Magistretti and Chatton 2005). 17 
For intracellular ATP level measurements, astrocytes were treated with 3/2 ratio of Lipofectamine 18 
(Life Technologies) and DNA encoding for FRET sensor AT1.03 (ATeam cyto, Imamura et al. 19 
2009). After 4h, the medium was changed with DMEM plus 10% serum, and cells were used for 20 
experiments 2 days after transfection.  21 
Acute brain slice preparation and electrophysiological recordings 22 
Experiments were performed on layer II/III neocortical astrocytes in acute slices obtained from 3 23 
week-old C57BL/6 mice. After decapitation and brain extraction, 250μm-thick coronal slices were 24 
prepared with a vibratome (VT 1000S, Leica). For astrocyte recordings, slices were incubated 25 
with an astrocyte-specific dye, sulforhodamine 101 (SR101, 1μM, 20 min at 32°C) before being 26 
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transferred to the recording chamber. Slices were then held down by a platinum harp and 1 
superfused by oxygenated 32°C artificial cerebrospinal fluid (ACSF). Recording chamber was 2 
attached to a Zeiss LSM510 Meta upright microscope equipped with infrared–differential 3 
interference contrast and allowing for visualization of SR101-labeled cells. Astroglial cells were 4 
selected in layer II/III by their small soma size (<10µm) and SR101 staining, and then recorded 5 
in whole-cell configuration. They were identified by their linear current-voltage (I-V) relationship, 6 
the lack of action potentials, and their characteristic negative resting potential (-77.8±0.6mV). 7 
External ACSF solution contained (in mM): NaCl 125, KCl 3, NaHCO3 26, CaCl2 2, MgCl2 2, 8 
NaH2PO4 1.25, glucose 10 and bubbled with 95% O2, 5% CO2.  9 
Whole-cell patch-clamp was obtained with borosilicate glass pipettes (>8MΩ, 4-6 MΩ and 5-7 MΩ 10 
resistance for layer III neurons, astrocytes and HEK-GLT-1 cells, respectively). The patch-clamp 11 
intracellular solution contained (in mM): K-gluconate 124, NaCl 6, KCl 6, MgCl2 3, EGTA 1, CaCl2 12 
0.5, HEPES 10, glutathione 2, Mg-ATP 3, and Na3-GTP 0.3 for astrocytes and K-gluconate 120, 13 
NaCl 5, KCl 5, MgCl2 1, EGTA 0.1, CaCl2 0.025, HEPES 10, glucose 4, Mg-ATP 1, and Na3-GTP 14 
0.2 for neurons (pH 7.3 with KOH, 290mOsm). Recordings were obtained in voltage-clamp 15 
configuration using a Multiclamp 700B amplifier (Molecular Devices) in gap-free mode with a 16 
holding potential set at -80mV. Data were acquired at 10kHz and filtered at 2kHz by a Digidata 17 
1440 analog-to-digital converter, controlled with the pCLAMP 10 software. Criteria for experiment 18 
inclusion in data analysis were based on the verification of stable access resistance and stable 19 
injected current (≤100pA at -80mV in 3mM K+ solution).  20 
During electrophysiological experiments for assessment of the glial glutamate uptake in acute 21 
brain slices, D-AP5 (50μM) was applied 5min before the onset of recordings and throughout the 22 
experiment. External solutions of 3mM, 5.4mM, and 8mM K+ were sequentially superfused in 23 
randomized order over HEK-GLT-1 cells or acute slices. For each of these conditions, and after 24 
the measured current stabilized, the same solution with either 200µM glutamate (HEK-GLT-1 25 
cells) or 1mM D-aspartate (D-Asp, acute brain slices) was delivered in the bath until maximal 26 
response was observed, and upon maximal response was washed out. 27 
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To measure the effect of increased [K+]o on the excitatory neurotransmission in acute brain slices, 1 
we recorded mini-excitatory post-synaptic currents and potentials (mEPSCs and mEPSPs) from 2 
layer II/III neurons in the whole-cell patch clamp configuration in 3 vs. 6mMK+. Recordings were 3 
performed in presence of tetrodotoxin (TTX, 1μM) and bicuculline (60μM) to block Nav channels 4 
and spiking activity, and GABAergic neurotransmission, respectively. The holding potential for 5 
mEPSC recordings was -80mV. No current was injected for mEPSP recording, allowing the 6 
membrane potentials of cells to vary upon different [K+]o applications. For mEPSC/P recordings, 7 
each condition was monitored for 10 minutes and the last 2 were analyzed. Cells included in the 8 
analysis had a membrane potential <-55 mV or < 150 pA of current injected for a voltage held at 9 
-70mV, stable access resistance, and recovery after washout. mEPSCs were primarily mediated 10 
by non-NMDA glutamate receptor activation, as they were blocked by application of the non-11 
NMDA glutamate receptor antagonist CNQX (10µM), but not by the application of the NMDAR 12 
antagonist D-AP5 (50µM) nor the presence of the GABAR antagonist bicuculline (60µM, data not 13 
shown). 14 
Data analysis and statistics 15 
Fluorescence intensity traces were drawn from up to 10 individual cells from the field of view. 16 
Current amplitude measurements were assessed using Clampfit (Molecular Devices). mEPSCs 17 
median amplitudes and mean frequencies were measured after automatic detection followed by 18 
manual editing of the events in MiniAnalysis (Synaptosoft) for baseline, test condition(s), and 19 
washout. Further calculations were done with Excel (Microsoft). Graphs, curve fitting, and 20 
statistical analyses were done using KaleidaGraph (Synergy Software). Unless otherwise 21 
indicated, a one-way ANOVA was performed for each experimental group to assess the statistical 22 
significance against respective controls, *, **, and *** refer to p values lower than 0.05, 0.01, and 23 
0.001, respectively.  24 
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Drugs 1 
D-AP5 was obtained from Biotrend, TTX, SNX482, and -Agatoxin-TK from Alomone Labs and 2 
bicuculline, (2S, 3S)-3-[3-[4-(trifluoromethyl)benzoylamino]benzyloxy]aspartate (TFB-TBOA) and 3 
LY341495 from Tocris Bioscience. All other chemicals were from Sigma-Aldrich. 4 
 5 
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Results 1 
[K+]o influences glutamate transporter responses 2 
Glutamate transporter activity was dynamically monitored by measuring the [Na+]i changes 3 
associated with transport activity (Chatton et al. 2000) using the sodium sensitive dye Asante 4 
Natrium Green 1 (ANG-1) (Lamy and Chatton 2011). Virtually all cells responded to glutamate 5 
application with a rapid and reversible increase in [Na+]i as previously observed (Rose and 6 
Ransom 1996; Chatton et al. 2000; Lamy and Chatton 2011). ANG-1-loaded astrocytes were 7 
superfused with various [K+]o concentrations spanning the described extracellular concentration 8 
range found in vivo during physiological and pathological activity, namely 3, 5.4, 8, 10 and 15mM, 9 
and ANG-1 signal was imaged (Fig. 1A). After a stable baseline was achieved in each [K+]o 10 
condition, glutamate (200µM) was applied. Fig. 1A depicts representative cell responses to 11 
glutamate application in 5.4 and 15mM [K+]o. As seen on the trace, resting [Na+]i levels were 12 
modulated by [K+]o (Fig. 1B). Increasing [K+]o from 3 to 15mM monotonically decreased baseline 13 
[Na+]i from 14.71±1.15 to 5.54±0.60mM (Fig. 1C). These findings are consistent with previous 14 
reports on  [Na+]i homeostasis revealing the involvement of Na,K-ATPase and Na,K,Cl 15 
cotransporter (NKCC) (Rose and Ransom 1996; Bittner et al. 2011). As described previously 16 
using SBFI, another Na+ sensitive indicator (Chatton et al. 2000), glutamate application also 17 
caused a rapid rise of [Na+]i that returned to baseline after washout of glutamate (Fig. 1B). The 18 
amplitude of the glutamate-induced Na+ response was increased by 12% in low [K+]o (3mM) 19 
compared to the amplitude recorded at 5.4mM [K+]o. Conversely, high [K+]o decreased the 20 
response by more than 65% (Fig. 1B&D). Analysis of the initial linear rate of [Na+]i rise (i.e. first 21 
10-20sec) (Fig. 1E) showed that glutamate in low [K+]o evoked an almost twofold faster increase 22 
in [Na+]i (24.30±1.56mM.min-1) compared to the response in high [K+]o (13.62±0.94mM.min-1). 23 
Control experiments performed using the ratiometric Na+-sensitive probe SBFI yielded the same 24 
results, indicating that the observed effects are not attributable to a [K+]o-induced swelling of 25 
astrocytes (Fig. S1). These results show that [K+]o fluctuations have a strong impact on the 26 
glutamate-induced Na+ response in astrocytes.  27 
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Acute effects of [K+]o on the Na+ response to glutamate 1 
We next investigated whether the observed [K+]o modulation of glutamate transport required the 2 
establishment of a steady-state K+-gradient across the plasma membrane. We compared 3 
glutamate response under different conditions (Fig. 2A): glutamate application in 3mM [K+]o 4 
steady-state conditions vs. acute applications of glutamate and 3mM [K+]o. Here, where cells were 5 
not allowed time to adjust intracellular cation levels, the amplitude of [Na+]i response was further 6 
enhanced compared to the control condition with steady-state baseline [K+]o. It even almost 7 
doubled the response amplitude observed in 5.4mM [K+]o (Fig. 2B). The analysis of the initial rate 8 
of [Na+]i rise (Fig. 2C) showed the same trend for glutamate application in low [K+]o in both acute 9 
and steady-state conditions. Extended to higher [K+]o concentrations, this analysis revealed that 10 
the inhibitory effects of [K+]o are also more marked for synchronized applications (Fig. 2D&E). 11 
Thus, the effects of [K+]o on glutamate transport are compatible with a direct and immediate action 12 
on the glutamate-induced response. They also indicate that synchronized glutamate and [K+]o 13 
application, closer mimicking the in situ situation, leads to steeper and more pronounced effects. 14 
The involvement of the glutamate transporter as the direct target of K+-modulation was confirmed 15 
by using D-Asp, a non-metabolized substrate of the glutamate transporters that does not activate 16 
non-NMDAR, which yielded a similar trend in amplitude, initial slope, and potentiation in acute 17 
application as they did with glutamate (Fig. S2). 18 
 [K+]o effects are not mediated by intracellular pH changes 19 
[K+]o elevations are known to cause a alkalinization of astrocyte cytosol that is mediated by the 20 
electrogenic bicarbonate transporter NBCe1 (Deitmer and Rose 1996; Schmitt et al. 2000; 21 
Chesler 2003; Ruminot et al. 2011). Depolarization causes this transporter to operate in reverse 22 
mode leading to HCO3- influx and alkalinization. To exclude that pH changes mediate the observed 23 
[K+]o modulation, CO2/HCO3--buffered salines were replaced by HEPES-buffered salines in which 24 
no intracellular pH change was found to occur upon switching [K+]o (data not shown). Fig. S3 25 
shows that the effects of [K+]o closely match those found in the presence of HCO3. These 26 
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experiments indicate that cellular alkalinization is not the key mediator of the [K+]o effect on the 1 
response to glutamate. 2 
[K+]o modulates the kinetics of the glutamate transporter 3 
Since glutamate transporters and the Na,K-ATPase both contribute to the shaping of the Na+ 4 
response to glutamate (Chatton et al. 2000), we investigated whether Na,K-ATPase activity was 5 
involved in the observed modulatory effects of [K+]o. The pump inhibitor ouabain (1mM) was 6 
applied for 1min before superfusing astrocytes with glutamate, which caused [Na+]i to slowly rise 7 
(Fig. 3A). The addition of 200µM glutamate induced a sudden acceleration of the [Na+]i rise that 8 
lasted until glutamate washout. Fig. 3B shows that during Na,K-ATPase inhibition, the response 9 
slope was markedly larger in 3 vs. 5.4mM [K+]o. In a further analysis, the rate of [Na+]i rise (i.e. 10 
local slope) was plotted against time (Fig. S4) and showed a significantly higher slope in the first 11 
minute of glutamate-induced Na+ response for lower [K+]o. This analysis also showed that the 12 
decline of Na+ influx rate, i.e. transporter deactivation (Chatton et al. 2000), occurred in both 13 
situations and tended to converge over time. Under our experimental conditions, the rodent Na,K-14 
ATPase is rapidly and completely blocked by application of a high concentration of ouabain (1mM) 15 
consistent with both experimental (O'Brien et al. 1994; Chatton et al. 2000; Chatton et al. 2003) 16 
and modelling (Chatton et al. 2000) results. These experiments indicate that the effects of [K+]o 17 
on the response to glutamate do not require Na,K-ATPase activity and point to an effect on 18 
glutamate transporter itself.  19 
 [K+]o modulation of glial glutamate transporter currents in HEK-GLT-1 cells are not mediated by 20 
changes in membrane potential (Vm) 21 
The electrogenicity of glutamate transporters makes them sensitive to Vm (Huxley and Stampfli 22 
1951). Under our experimental conditions, in acute cortical slices, we observed that increasing 23 
the [K+]o from 3 to 5.4mM caused a 6.4mV depolarization of the astrocyte membrane (data not 24 
shown). To investigate whether the voltage-dependence of glutamate transport might underlie the 25 
observed [K+]o effects on the Na+ response, the transporter current was assessed using whole-26 
Cerebral Cortex, June 2017;27: 3272–3283  Rimmele, Rocher, Wellbourne-Wood & Chatton 
 
13 
 
cell patch-clamp in HEK-GLT-1 cells clamped at -80mV. Glutamate (200M) applications induced 1 
an inward current (Fig. 4A) that was inhibited by bath application of the specific glutamate 2 
transporter inhibitor TFB-TBOA (200nM, Fig. S5) (Shimamoto et al. 2004; Bozzo and Chatton 3 
2010). Both the amplitude and the time course of the glutamate associated current were 4 
decreased with rising [K+]o from 3 to 8mM (Fig. 4B). This observation, made at clamped voltage, 5 
confirms that the [K+]o associated modulation of glutamate transport activity is not solely due to 6 
its effect on membrane potential. 7 
[K+]o modulates glial glutamate transporter currents in cortical slices 8 
We then investigated whether [K+]o also affected astrocyte responses in situ. We recorded 9 
astrocytes of layer II/III mouse cortex in the whole-cell patch clamp configuration. Astrocytes were 10 
clamped at -80mV and membrane currents recorded (Fig. 4C). We found that bath application of 11 
D-Asp (1mM) in the presence of NMDAR antagonist D-AP5 caused a marked inward current that 12 
TFB-TBOA could inhibit by 81% (Fig. S5), confirming that glutamate transporters are responsible 13 
for the observed response induced by D-Asp. Fig. 4D indicates that the [K+]o modulation of 14 
glutamate transporters is present in astrocytes in situ and can also be assessed by its associated 15 
transporter current. 16 
Energy metabolic consequences of the [K+]o modulation of glutamate transport  17 
Astrocytic energy demands are tightly coupled to the Na+ load caused by glutamate uptake and 18 
the consecutive activation of the Na,K-ATPase (Magistretti et al. 1999; Magistretti and Chatton 19 
2005). To assess how these energy demands are influenced by [K+]o, we monitored changes of 20 
intracellular free Mg2+ using the fluorescent probe MgG, as described before (Magistretti and 21 
Chatton 2005), as well as using the genetically-encoded ATP sensor ATeam (Imamura et al. 22 
2009). We found that [K+]o increases alone decreased ATP hydrolysis (Fig. S6 A&B), an 23 
observation compatible with Na,K-ATPase activity changes (see Fig. 3). We then found that 24 
increasing [K+]o negatively modulated both the amplitude of the ATP hydrolysis response (Fig. S6 25 
C&D) and the drop of cytosolic ATP levels (Fig. S6 F&G) caused by 200µM glutamate application. 26 
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These measurements indicate that the inhibition of glutamate transporter activity observed in high 1 
[K+]o is accompanied by lower rates of ATP hydrolysis, and hence lower energy demands. 2 
Increasing [K+]o decreases mEPSCs frequency in acute brain slices  3 
[K+]o elevations of 3mM from baseline are very likely to occur during non-pathological neuronal 4 
activity (Heinemann and Lux 1977). Such a change falls within the range of ~50% inhibition of the 5 
astrocytic glutamate transporter associated current according to our measurements (Fig. 4D). As 6 
an initial hypothesis, one could expect synaptic transmission to be potentiated in 6 vs. 3mM [K+]o 7 
because of (i.) the rise of extracellular glutamate concentrations due to weakened clearance 8 
efficacy, (ii.) the depolarizing effect on cell membrane potential associated with increased [K+]o. 9 
To test this hypothesis, we evaluated the outcome of changing [K+]o from 3 to 6mM on basal 10 
excitatory neurotransmission. Fig. 5A shows electrophysiological traces of mEPSCs from 11 
representative neurons in layer II/III in acute cortical slices. The mean frequency of mEPSCs 12 
significantly decreased by 35% with the bath application of 6mM [K+]o (Fig. 5F) suggesting a 13 
depression of glutamate release with higher [K+]o. The mean amplitude or the kinetics of mEPSCs 14 
did not differ as illustrated by a corresponding superimposed averaged individual event trace (Fig. 15 
5D&F). Representative cumulative percentile histograms (Fig. 5E) revealed the dramatically 16 
altered frequency distribution (K–S test, z=3.37; p<0.001, 6mM [K+]o vs. baseline) and the modest 17 
change in amplitude distribution (z=2.36; p<0.001). These findings indicate that increased [K+]o, 18 
which we showed to cause depression of glutamate uptake, did not enhance but rather dampened 19 
basal excitatory neurotransmission. We next investigated mechanisms that could underline this 20 
overall inhibitory activity associated with increased [K+]o.  21 
The inhibitory effect of increased [K+]o on excitatory neurotransmission requires mGluR2,3 22 
activation 23 
Glutamate spillover occurring consecutively to pharmacological inhibition of glutamate 24 
transporters (Maki et al. 1994; Iserhot et al. 2004; Tsukada et al. 2005) or in a brain region with 25 
decreased glial coverage (Oliet et al. 2001) has been proposed to decrease glutamate release 26 
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via presynaptic mGluR activation. The inhibitory effect of increased [K+]o on glutamate transport 1 
could mobilize similar mechanisms. We targeted group II metabotropic receptors, associated with 2 
Gi proteins, known to decrease the probability of glutamate release upon activation. These 3 
receptors are expressed in the mouse neocortex (Reid and Romano 2001). Fig. 5B shows the 4 
representative mEPSCs traces at 3 and 6mM [K+]o in the presence of LY341495 (50nM), the 5 
specific and potent antagonist of group II mGluRs (Kingston et al. 1998) and the corresponding 6 
averaged individual event trace of mEPSCs (Fig. 5D, middle). LY341495 application itself had no 7 
significant effect on either frequency or amplitude (data not shown). However, in the presence of 8 
the mGluR2,3 blockade by LY341495, elevated [K+]o failed to induce any changes in either mEPSC 9 
frequency or amplitude (Fig. 5F). These analyses confirm that the depression of excitatory 10 
synaptic activity exerted by an increased [K+]o is blocked by mGluR2,3 activation. 11 
[K+]o does not potentiate the activation of NMDARs 12 
Glutamate receptor-mediated mEPSCs were recorded at a holding voltage of -80mV, which does 13 
not allow for investigating the post-synaptic NMDAR opening probability, which might be 14 
increased by [K+]o-associated membrane depolarization. Depolarization has been indeed 15 
reported to alleviate the Mg2+ block from the NMDAR channel pore (Espinosa and Kavalali 2009). 16 
To investigate whether NMDAR activation was mediated by the change in membrane voltage 17 
associated with the increase in [K+]o, we repeated the previous experiment measuring mEPSPs. 18 
The NMDAR antagonist D-AP5 (50μM) was applied in addition to 6mM [K+]o (see representative 19 
traces in Fig. 5C). Electrophysiologically characterized cells were depolarized by -6.94±1.51mV 20 
(p<0.01, n=6, data not shown) in increased [K+]o vs. baseline condition. The changes in mEPSP 21 
frequency while applying 6mM [K+]o were similar to what found with the mEPSC recordings, i.e. a 22 
reduction of the frequency of events by one third in 6mM [K+]o while the amplitude of these 23 
excitatory events was not significantly different from the baseline (Fig. 5D bottom). The presence 24 
of D-AP5 revealed a further decrease of the amplitude of events (-10%), but was not significant 25 
compared to the 6mM [K+]o condition. These data suggests that higher [K+]o does not cause a 26 
significant activation of NMDAR located on either the pre- or post-synaptic sides (Fig. 5F).  27 
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 [K+]o does not potentiate the activation of pre-synaptic voltage dependent calcium channels 1 
K+-associated membrane depolarization could also modify glutamate neurotransmission from the 2 
presynaptic side via the pre-synaptic voltage dependent calcium (Cav) channels. To test this 3 
hypothesis, mEPSCs were recorded in the presence of the Cav blockers ω-agatoxin TK (120nM) 4 
and SNX-482 (60nM), specific blockers of the presynaptic subtypes, the P/Q type Cav2.1 and R 5 
type Cav2.3, respectively (Teramoto et al. 1997; Newcomb et al. 1998). This set of experiments 6 
(Fig. S7) shows that the reduction of mEPSC frequency associated to elevated [K+]o was not 7 
significantly more pronounced in presence of the Cav blockers. 8 
 [K+]o and TFB-TBOA share inhibitory actions on mEPSCs  9 
The depression of mEPSCs frequency associated with increased [K+]o was similar to the effects 10 
reported during pharmacological inhibition of the glutamate transporter (Maki et al. 1994; Oliet et 11 
al. 2001; Reid and Romano 2001; Iserhot et al. 2004), which was shown to be the consequence 12 
of extrasynaptic glutamate spillover and subsequent activation of presynaptic neuronal group II 13 
mGluRs. To our knowledge, such mechanisms have not been reported in the mouse neocortex 14 
where our studies were made. We therefore tested the outcome of pharmacological inhibition of 15 
glutamate transport on synaptic neurotransmission in this brain region. TFB-TBOA was applied 16 
in 3mM [K+]o at 80nM, a concentration causing a ~40% inhibition of glutamate transporters (Bozzo 17 
and Chatton 2010), and we observed a 28.6±7.3% (p=0.03, n=4) decrease in mEPSCs frequency 18 
with no change in amplitude, recapitulating observations made in other brain regions (data not 19 
shown). In another set of experiments (n=5 cells), we compared the effects of TFB-TBOA in 3 vs. 20 
6mM [K+]o. Fig. 5G again shows a decrease in mEPSCs mean frequency–but not in amplitude—21 
in the presence of TFB-TBOA combined or not with increased [K+]o. Thus, the extent of inhibition 22 
caused by TFB-TBOA is not additive to the one caused by 6mM [K+]o, suggesting that TFB-TBOA 23 
and elevated [K+]o share a common mechanism of action. Therefore, [K+]o may be considered the 24 
first physiological mediator of glutamate transporter inhibition. 25 
 26 
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Discussion  1 
A remarkable finding of our study is that increased [K+]o represents a prominent physiological 2 
inhibitor of glutamate uptake, which has unanticipated fundamental functional implications. While 3 
[K+]o induced inhibition of glutamate transporters should increase the glutamate concentration in 4 
the synaptic cleft, we observed it ultimately leads to the overall depression of mEPSC frequency, 5 
notably via a presynaptic mechanism involving the activation of mGluR2,3 metabotropic receptors.  6 
[K+]o changes in the brain 7 
In vivo, [K+]o levels have been shown to undergo substantial fluctuations during physiological and 8 
pathological conditions. During activity, repolarization of the neuronal membrane leads to an 9 
increase of [K+]o in the proximity of active neurons, as well as in the surrounding network due to 10 
diffusion. Without adequate regulation, an accumulation of extracellular K+ would rapidly abolish 11 
electrical activity. Astrocytes are equipped with active and passive mechanisms for K+ uptake, 12 
such as inwardly rectifying K+ channels (Kir), Na+/K+/Cl- cotransporters, and Na,K-ATPase. 13 
Astrocytes form a syncytium, and using these clearance mechanisms, they collectively perform 14 
rapid K+ redistribution in the brain (Kofuji and Newman 2004). Of particular note is the Kir4.1 15 
channel, which is abundant in synaptic regions and perivascular endfeet (Higashi et al. 2001). 16 
Interestingly, it has been demonstrated that functional Kir4.1 expression is decreased in a mouse 17 
model of Huntington's disease (HD), which leads to striatal [K+]o elevation (Tong et al. 2014). This 18 
could be reversed by viral delivery of Kir4.1 channels to striatal astrocytes. In addition, there are 19 
indications of interactions between the glutamate and K+ clearance mechanisms, as suggested 20 
by the demonstration of impaired glutamate uptake described in a Kir4.1 knock-out mouse model 21 
(Djukic et al. 2007). 22 
While [K+]o level is ~3mM at rest, it may reach a concentration of ~12mM during epileptiform 23 
activity (Kofuji and Newman 2004). Accordingly, our study investigated the cross-talk between 24 
glutamate transport and [K+]o levels in the 3-15mM range. The default concentrations of external 25 
potassium were set at different values in the in vitro vs. ex vivo experiment. For primary astrocyte 26 
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experiments, the default external K+ concentration was set to 5.4mM in order to maintain the K+ 1 
concentration used in cell culture medium and prevent any initial K+ change. A 3mM K+ 2 
concentration point was added to the set of cultured cells experiments as matter of comparison 3 
with the ex vivo acute slice experiments. 4 
 [K+]o-dependent glutamate transport modulation  5 
During activity, astrocyte processes surrounding synapses are exposed to both glutamate and 6 
K+, which are increased in the same time window. Glutamate is rapidly removed from the 7 
extracellular space both by Na+-coupled glutamate transporters, expressed at high density at the 8 
astrocyte membranes ensheathing the synaptic elements (Danbolt 2001), and by those present 9 
at the synaptic elements themselves (Rimmele and Rosenberg 2016).  10 
The present study provides evidence for a K+-dependent modulation of glutamate uptake. For the 11 
same glutamate concentration applied, the amplitude of [Na+]i response decreased by 3.5-fold 12 
within the range from 3 to 15mM [K+]o in situations of steady-state [K+]o. Interestingly, when 13 
investigating the time dependency of the effect of [K+]o on glutamate transport, we found that 14 
synchronized high [K+]o and glutamate application led to a more pronounced reduction in the 15 
response compared to glutamate application in a steady-state condition. Such simultaneous and 16 
localized variations in both K+ and glutamate might be more reflective of what the membrane 17 
processes of the astrocyte that tightly ensheathe synapses in vivo actually face. Given the 18 
immediacy of the responses we observed to [K+]o changes, significant contribution of intracellular 19 
signaling pathways or biochemical processes such as phosphorylation or protein trafficking is 20 
unlikely. For example, cAMP production increases associated with K+ elevation requires a few 21 
minutes delay (Choi et al. 2012). Furthermore, the presence of bicarbonate is necessary for this 22 
cAMP rise to occur as it depends on the bicarbonate-dependent activation of soluble adenylate 23 
cyclase. The [K+]o-regulated uptake we report here is immediate and effective in bicarbonate-free 24 
solutions and is therefore unlikely to be associated with cAMP changes. 25 
Cerebral Cortex, June 2017;27: 3272–3283  Rimmele, Rocher, Wellbourne-Wood & Chatton 
 
19 
 
Several lines of evidence indicated that glutamate transporters are the prime target of this 1 
regulation by [K+]o, as the same phenomenon was observed using the transporter substrate D-Asp 2 
both in primary cultures and in acute slices. Moreover, the [K+]o effect persisted in the presence 3 
of ouabain, excluding a direct role of Na,K-ATPase, as could have been envisaged based on the 4 
reported physical and functional association between glutamate transporters and the pump 5 
(Cholet et al. 2002; Rose et al. 2009; Matos et al. 2013). In addition, as the glutamate transport 6 
cycle is electrogenic, variations of the membrane potential associated with [K+]o changes could 7 
underlie the observed modulation. However, glutamate transport studied in voltage-clamp mode 8 
in HEK-GLT-1 cells or in astrocytes in acute brain slices exhibited the same [K+]o modulation as 9 
in non-voltage clamped cells, consistent with a [K+]o effect that is not entirely attributable to 10 
membrane potential changes.  11 
Proposed mechanism of the [K+]o-mediated modulation of transport 12 
Glutamate transport has a complex stoichiometry of three Na+ and one H+ entering with glutamate 13 
in exchange for one K+ (Zerangue and Kavanaugh 1996). Transport steps occur in two half-14 
cycles: first glutamate is co-transported with three Na+ ions and one H+ which is followed by a 15 
reorientation of the binding sites upon countertransport of K+ in a 'ready for uptake' position, with 16 
the outward facing side (Kanner 2006). It has been proposed that an elevation of [K+]o would 17 
increase the proportion of transporters in the inward-facing conformation and therefore limit the 18 
transport cycling rate (Kanner 2006). This is supported by experiments performed with brain 19 
plasma membrane saccules, where external K+ had an inhibitory effect on vesicle uptake of 20 
glutamate in the low millimolar range (Danbolt and Storm-Mathisen 1986), which also occurred in 21 
the presence of ionophores or in the absence of transmembrane ion gradients. This K+-mediated 22 
inhibition of glutamate uptake could therefore constitute the predominant mechanism underlying 23 
the [K+]o modulation in the present study.  24 
The structural basis for glutamate transport function is under thorough research, among which 25 
investigations focused on the K+ binding site. Targeted mutations in the K+ binding site preventing 26 
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binding caused the abortion of the glutamate transport cycle of the mutated GLT-1 (Kavanaugh 1 
et al. 1997). These experiments suggest that interfering with the countertransport of K+ might 2 
impede the rate of glutamate transport. An additional model reviewed by Vandenberg and Ryan 3 
(2013) proposed that the glutamate transporter would be equipped with an additional K+ binding 4 
site that would overlap with that of glutamate. According to this latter hypothesis, the subsequent 5 
binding competition between glutamate and K+ would directly challenge glutamate uptake, 6 
especially in conditions of increased [K+]o. 7 
Functional implications of [K+]o dependent glutamate uptake 8 
This modulation of glutamate transport by [K+]o has several important functional implications, 9 
considering the fluctuations of [K+]o occurring during neuronal activity in both physiological and 10 
pathological conditions (for reviews, see Kofuji and Newman 2004; Sykova and Nicholson 2008). 11 
An increase of +3mM [K+]o from basal [K+]o leads to a reduction to 60% of glutamate transporter 12 
current in astrocytes. This novel K+-dependent regulation of the glutamate transporter could be 13 
proposed as a mechanistic hypothesis for the recent findings of Armbruster et al. (2016). This 14 
study shows, in cortical slices, a slowing down of glutamate uptake, assessed by an extracellular 15 
glutamate sensor that is dependent on the frequency and duration of neuronal activity rather than 16 
on the amount of glutamate released. In this context, [K+]o , raising during sustained neuronal 17 
activity, possibly tunes down the glutamate uptake.  18 
One could wonder what the functional advantage of such a modulation of glutamate transport by 19 
[K+]o would be. At the bioenergetic level, Na+-coupled glutamate transport activity, tightly coupled 20 
with the Na,K-ATPase (Magistretti and Chatton 2005), comes with a substantial energy cost. An 21 
increase in [K+]o is expected to decrease pump-associated cost by two mechanisms. (i) Baseline 22 
[Na+]i in astrocytes is influenced by [K+]o, as reported in the present study and previously (Rose 23 
and Ransom 1996; Bittner et al. 2011). [Na+]i is lowered in high [K+]o and energy measurements 24 
converge towards a decrease in ATP consumed by the Na,K-ATPase or an increased ATP/ADP 25 
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ratio. (ii) A [K+]o-modulated decrease of glutamate uptake will cause a corresponding reduced 1 
Na,K-ATPase response, and associated ATP hydrolysis.  2 
At the level of neuronal network activity, the pharmacological impairment of glutamate transporter 3 
activity is reported to favor glutamate accumulation and spillover (Tsukada et al. 2005). 4 
Accordingly, increased [K+]o and its inhibitory action on glutamate transporters would also be very 5 
likely to lead to comparable glutamate accumulation in addition to cell membrane depolarization. 6 
Rather than potentiating synaptic glutamate transmission, we found that a moderate increase in 7 
[K+]o caused a depression of excitatory pre-synaptic transmission via an indirect mechanism, 8 
involving a decrease in synaptic vesicle release probability. To test this hypothesis in our 9 
conditions, we applied LY341495, a potent antagonist of group II mGluR (Kingston et al. 1998), 10 
which completely abolished the depressive effect of increased [K+]o on mEPSCs frequency. Our 11 
findings are consistent with previous studies employing a pharmacological inhibition of glutamate 12 
uptake and reporting a depression of excitatory synaptic transmission due to the activation of 13 
group II mGluRs (Maki et al. 1994; Reid and Romano 2001; Iserhot et al. 2004). Group II mGluR 14 
encompasses mGluR2,3 which have been shown to be expressed in the adult mouse cerebral 15 
cortex (Reid and Romano 2001; Renger et al. 2002), mainly at the neuronal presynaptic 16 
membrane (Jin et al. 2016). These Gi/o coupled receptors are reported to inhibit cAMP signaling 17 
and, downstream, neurotransmitter release (Benneyworth et al. 2007). While application of either 18 
6mM [K+]o or TFB-TBOA, a potent inhibitor of glutamate transporters (Shimamoto et al. 2004), 19 
depressed mEPSCs frequency –but not amplitude—by about 30%, applying a combination of 20 
both 6mM [K+]o and TFB-TBOA did not cause an additional depression of mEPSCs. These non-21 
additive effects indicate that pharmacological and K+-dependent inhibition of glutamate transport 22 
dampen excitatory presynaptic transmission through shared mechanisms. This negative 23 
feedback on excitatory neurotransmission elicited by increased extracellular potassium through 24 
scaling down of glutamate transport could be considered a plausible scenario in a situation where 25 
neuronal activity might be blocked. For example in the epilepsy study of Bazzigaluppi et al. (2016), 26 
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K+ application alone in an in vivo mouse model did not trigger the seizures observed with the 4-1 
aminopyridine application, although increased [K+]o was of similar magnitude in both conditions. 2 
Conclusion 3 
We show that the glutamate concentration in the synaptic cleft does not only depend on calcium 4 
dependent release, but also on the [K+]o-dependent control of glutamate uptake. These two 5 
parameters happen to be linked, as we unveiled a novel negative feedback cascade linking [K+]o 6 
elevation, glutamate transporter inhibition, and presynaptic mGluR activation. This mechanism 7 
depicted in Fig. 6 could be fundamental for efficiently constraining excitatory neuronal activity in 8 
presence of raising [K+]o, likely to occur during sustained neuronal activity. This study shows that 9 
the K+-coupling of glutamate transport represents a way of tuning synaptic transmission, not 10 
envisaged to date.  11 
While the role of glutamate transporter in brain tissue is extensively studied –notably in the context 12 
of pathologies- it is with the general assumption that its transport capabilities are mainly 13 
determined by its level and pattern of expression. In this study, we unveil that these parameters 14 
are not the only determinants of glutamate uptake efficiency. [K+]o is known to have a strong 15 
impact on neuronal excitability, and is also altered in several pathologies such as epilepsy 16 
(Frohlich et al. 2008) and HD (Tong et al. 2014). Now [K+]o, as a physiological modulator of 17 
glutamate transport, must also be considered when studying glutamate transport efficiency. The 18 
subtle interplay between K+ and glutamate transport in both physiological and pathological 19 
conditions is of paramount importance and needs to be considered to better understand glutamate 20 
homeostasis. 21 
 22 
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Captions  1 
Fig. 1. [K+]o influences the [Na+]i response to glutamate. (A) Images of ANG-1-loaded astrocytes 2 
shown in gray scale (left) and in color coded amplitude of fluorescence change observed for 3 
glutamate application in 5.4 (middle) and 15mM (right) [K+]o. Scale bar: 50µm. (B) Single-cell 4 
representative trace of [Na+]i responses to 200µM glutamate superfusion in 3, 5.4 and 10mM [K+]o. 5 
The [Na+]i response to glutamate was modulated by the level of [K+]o. Mean values of (C) baseline, 6 
(D) amplitude, and (E) initial slope were normalized to the value measured at 5.4mM [K+]o and 7 
plotted against [K+]o (n=168 cells, 17 exp) and showed a linear relationship. 8 
 9 
Fig. 2. Acute effects of [K+]o on the [Na+]i response to glutamate. (A) Representative trace of 10 
intracellular Na+ dynamics during 200µM glutamate superfusion in 5.4 and 3mM [K+]o with and 11 
without equilibration period. Mean amplitudes (B) and initial rate of [Na+]i rise (C) induced by 12 
glutamate in 5.4mM [K+]o (black bars) solutions compared with responses observed in 3mM [K+]o 13 
without (white bar) or with (grey bar) equilibration period (n=117 cells, 12 exp). (D-E) 14 
Synchronized glutamate and high [K+]o (open circles) led to a steeper modulation of the response 15 
amplitude (D) and initial rate of rise (E), in comparison with a steady-state situation (closed 16 
circles). (5.4mM [K+]o: n=58 cells, 6 exp; 10mM [K+]o: n=90 cells, 9 exp; 15mM [K+]o: n=80 cells, 17 
8 exp). 18 
 19 
Fig. 3. [K+]o effects on glutamate-induced [Na+]i response does not depend on the activity of the 20 
Na,K-ATPase. (A) Representative trace of [Na+]i dynamics during 200µM glutamate superfusion 21 
at 5.4 and 3mM [K+]o while blocking the Na,K-ATPase with 1mM ouabain (n=65 cells, 7 exp). The 22 
inset depicts the gradual [Na+]i increase induced by ouabain alone, then its acceleration upon 23 
addition of glutamate. (B) The initial rate of [Na+]i rise (mM.min-1) was calculated from the initial 24 
linear [Na+]i rise following glutamate application (n=65 cells,7 exp). 25 
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Fig. 4. [K+]o-modulation of the glutamate transporter current: electrophysiological responses of 1 
HEK-GLT-1 cells and astrocytes in acute slices in whole-cell voltage clamp. (A) Modulation by 2 
[K+]o of transporter current induced by 200µM glutamate superfusion of a HEK-GLT-1 cell. Inset: 3 
Corresponding current voltage (I/Vm) relationship. (B) Modulation of slow inward current induced 4 
by D-Asp (1mM) on an passive astrocyte clamped at -80mV in the brain slice under the influence 5 
of increasing [K+]o superfusion. Inset: I/Vm relationship of the same astrocyte. (C, D) Mean values 6 
±SEM of maximum inward current amplitude (top) or initial slope (bottom) in HEK-GLT-1 cells 7 
(n=5) or astrocytes (n=6) plotted against [K+]o in control condition. 8 
 9 
Fig. 5. [K+]o elevation decreases mEPSC frequency by a presynaptic mGluR II mechanism. (A, 10 
B, C) Representative mEPSCs (A, B) and mEPSPs (C) traces from cells recorded at 3mMK 11 
control and washout (top, bottom), 6mM [K+]o alone or in the presence of antagonists for mGluR2,3 12 
(LY341495, B) or for NMDA (AP5, C, middle). (D) Corresponding overlaid traces of mEPSC/Ps 13 
averaged from the cells in A (top), B (middle) and C (bottom) demonstrating similar kinetics in 3 14 
and 6mM [K+]o. (E) Cumulative probability distributions of mEPSC inter-event interval (top) and 15 
amplitude (bottom) from the same cell as in A during baseline (black line), 6mM [K+]o application 16 
(blue line) and washout (grey dashed line). (F) mEPSC/P frequency and amplitude (%) in 17 
response to elevated [K+]o alone or in the presence of mGluR2,3 or NMDAR blockers. Statistical 18 
significance was calculated against baseline values unless otherwise stated. (G) Effects of TFB-19 
TBOA and [K+]o on synaptic transmission. A depression of mEPSC frequency but not amplitude 20 
is observed upon glutamate transporter inhibition by TFB-TBOA alone. It is not potentiated by the 21 
combined application of both TFB-TBOA and increased [K+]o (n=5). 22 
 23 
Fig. 6. Summary scheme showing the new physiological roles of K+. This diagram depicts the 24 
impact [K+]o changes have on synaptic neurotransmission through glutamate uptake inhibition 25 
and mGluR2,3 activation. 26 
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